Skip to main content
logo
Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
146.57
-3.04 (-2.03%)
At close: Oct 10, 2025, 4:00 PM EDT
147.00
+0.43 (0.29%)
After-hours: Oct 10, 2025, 5:51 PM EDT

Biogen Revenue by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Multiple Sclerosis
4.18B4.23B4.35B4.45B4.55B4.61B4.66B4.76B
Multiple Sclerosis Growth
-8.10%-8.37%-6.70%-6.60%-7.90%-10.62%-14.15%-16.30%
Other
2.85B2.64B2.49B2.39B2.42B2.47B2.59B2.67B
Other Growth
17.43%7.12%-3.89%-10.48%-2.92%1.98%18.45%28.19%
Rare Disease
2.14B2.13B1.99B1.87B1.82B1.72B1.74B1.79B
Rare Disease Growth
17.34%23.36%13.99%4.21%2.78%-2.26%-2.77%0.82%
Biosimilars
761.10M777.50M793.60M779.80M777.50M774.50M770.00M756.60M
Biosimilars Growth
-2.11%0.39%3.06%3.07%3.68%3.38%2.52%-5.09%

Revenue by Geography

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
International
3.87B3.98B3.98B3.96B4.02B4.01B4.11B4.18B
International Growth
-3.72%-0.65%-3.14%-5.18%-6.11%-8.77%-9.25%-11.29%
United States
3.34B3.25B3.24B3.25B3.23B3.19B3.14B3.14B
United States Growth
3.33%1.85%3.05%3.53%0.92%-3.32%-9.45%-12.08%
Other Geographic
2.79B2.59B2.46B2.39B2.42B2.47B2.59B2.67B
Other Geographic Growth
15.16%4.90%-4.87%-10.48%-2.92%1.98%18.45%28.19%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.